176 related articles for article (PubMed ID: 12600957)
1. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.
Rossi E; Adams L; Prins A; Bulsara M; de Boer B; Garas G; MacQuillan G; Speers D; Jeffrey G
Clin Chem; 2003 Mar; 49(3):450-4. PubMed ID: 12600957
[TBL] [Abstract][Full Text] [Related]
2. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.
Grigorescu M; Rusu M; Neculoiu D; Radu C; Serban A; Catanas M; Grigorescu MD
J Gastrointestin Liver Dis; 2007 Mar; 16(1):31-7. PubMed ID: 17410286
[TBL] [Abstract][Full Text] [Related]
3. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
[TBL] [Abstract][Full Text] [Related]
4. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
Naveau S; Essoh BM; Ghinoiu M; Marthey L; Njiké-Nakseu M; Balian A; Lachgar M; Prévot S; Perlemuter G
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):404-11. PubMed ID: 24561990
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
[TBL] [Abstract][Full Text] [Related]
7. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
Ngo Y; Munteanu M; Messous D; Charlotte F; Imbert-Bismut F; Thabut D; Lebray P; Thibault V; Benhamou Y; Moussalli J; Ratziu V; Poynard T
Clin Chem; 2006 Oct; 52(10):1887-96. PubMed ID: 16931569
[TBL] [Abstract][Full Text] [Related]
8. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
Myers RP; Benhamou Y; Imbert-Bismut F; Thibault V; Bochet M; Charlotte F; Ratziu V; Bricaire F; Katlama C; Poynard T
AIDS; 2003 Mar; 17(5):721-5. PubMed ID: 12646795
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of the Coopscore
Taibi L; Boyd A; Bosselut N; Bottero J; Guéchot J; Lacombe K; Lasnier E; Baudin B; Vaubourdolle M
Ann Clin Biochem; 2018 Mar; 55(2):236-243. PubMed ID: 28661201
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.
Yakoob R; Bozom IA; Thandassery RB; Rahman MO; Derbala MF; Mohannadi MJ; John AK; Sharma M; Wani H; Kaabi SA
Ann Gastroenterol; 2015; 28(2):265-270. PubMed ID: 25830472
[TBL] [Abstract][Full Text] [Related]
13. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.
Shaheen AA; Wan AF; Myers RP
Am J Gastroenterol; 2007 Nov; 102(11):2589-600. PubMed ID: 17850410
[TBL] [Abstract][Full Text] [Related]
14. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.
Salkic NN; Jovanovic P; Hauser G; Brcic M
Am J Gastroenterol; 2014 Jun; 109(6):796-809. PubMed ID: 24535095
[TBL] [Abstract][Full Text] [Related]
15. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
Myers RP; Tainturier MH; Ratziu V; Piton A; Thibault V; Imbert-Bismut F; Messous D; Charlotte F; Di Martino V; Benhamou Y; Poynard T
J Hepatol; 2003 Aug; 39(2):222-30. PubMed ID: 12873819
[TBL] [Abstract][Full Text] [Related]
16. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
[TBL] [Abstract][Full Text] [Related]
18. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.
Sebastiani G; Vario A; Guido M; Alberti A
World J Gastroenterol; 2007 Jan; 13(4):525-31. PubMed ID: 17278217
[TBL] [Abstract][Full Text] [Related]
19. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
[TBL] [Abstract][Full Text] [Related]
20. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
